SALT LAKE CITY, Dec. 19, 2013 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a company dedicated to helping people achieve healthy living through a combination of a compelling business opportunity and scientifically validated products, announced today that Douglas C. Robinson, the Company's President and Chief Executive Officer will be presenting at the 16 th Annual ICR XChange, to be held January 13-15, 2014, at the JW Marriott Orlando Grande Lakes in Orlando, Florida. The LifeVantage Corporation investor presentation is scheduled for Monday, January 13, 2014, at 3:30 pm Eastern Time. The presentation will be webcast live and archived on the Investor Info portion of the Company's website at http://investor.lifevantage.com/events.cfm. About LifeVantage Corporation LifeVantage Corporation (Nasdaq:LFVN), a leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience® Anti-Aging Cream and LifeVantage® Canine Health, is a science-based network marketing company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and is headquartered in Salt Lake City, Utah. More information is available at www.LifeVantage.com. About the ICR XChange The ICR XChange is a unique platform where public and private company management teams, institutional investors, sell-side research analysts, investment bankers, private equity professionals and select media connect with one another with the goal of creating value, and understanding consumer trends and public company prospects as the year begins. The event is one of the largest investment conferences of the year, featuring presentations by more than 150 public and private companies, with attendance regularly exceeding 1,500. Click here to request an invitation to the ICR XChange.
CONTACT: Investor Relations Contact: Cindy England (801) 432-9036 Director of Investor Relations -or- John Mills (310) 954-1105 Senior Managing Director, ICR, LLC